{"id":"W4405375041","doi":"10.1016/j.iotech.2024.100746","title":"117O Stereotactic body radiotherapy (SBRT) with pembrolizumab (pembro) for unresected stage I/II non-small cell lung cancer (NSCLC): The randomized, double-blind, phase III KEYNOTE-867 study","year":2024,"lang":"en","type":"article","venue":"Immuno-Oncology Technology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Medical physics; Internal medicine; Cancer; Immunotherapy; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001287054,0.001518886,0.002613038,0.0004457401,0.0004323759,0.0009461566,0.0007268192,0.00142959,0.006152942],"category_scores_gemma":[0.0007495861,0.0007270101,0.001774604,0.0004919473,0.001123642,0.0008381627,0.00045158,0.002854526,0.001587058],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005999717,"about_ca_system_score_gemma":0.001312343,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001275901,"about_ca_topic_score_gemma":0.002102684,"domain_scores_codex":[0.9994544,0.0002752892,0.00002978933,0.00008441006,0.00004592106,0.0001101608],"domain_scores_gemma":[0.9995984,0.00008633477,0.0000819579,0.00004125191,0.00003127631,0.0001607583],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9701005,0.008177365,0.0006173941,0.0005065232,0.0009348468,0.00002118925,0.00002853336,0.0003120239,0.004420928,0.0001138976,0.0008159895,0.01395093],"study_design_scores_gemma":[0.9238359,0.07288223,0.00129801,0.00001975152,0.0004668285,0.0000248974,0.00001340455,0.0002079985,0.0006108389,0.00007654631,0.0005543747,0.000009105487],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9859611,0.003829568,0.0009122223,0.0004523642,0.0004881366,0.003491119,0.00132577,0.0001555489,0.003384244],"genre_scores_gemma":[0.9817343,0.003961542,0.001695366,0.00120202,0.0003764976,0.003790722,0.001979108,0.00004810311,0.005212345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006152942,"threshold_uncertainty_score":0.02058357,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0171213817156222,"score_gpt":0.3587965159867576,"score_spread":0.3416751342711354,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}